Sparta Launches Autonomous Medicine Project to Create Medical Decision Support for Transformational Healthcare Delivery in Challenging Locations
TORONTO, ON / ACCESSWIRE / May 25, 2023 / Sparta Group (TSXV:SAY) (the "Corporation", the "Company", "Sparta Group", "Sparta Capital", "SAY.V" or "Sparta") is launching an Autonomous Medicine Project, bringing together several of the Company's …
TORONTO, ON / ACCESSWIRE / May 25, 2023 / Sparta Group (TSXV:SAY) (the "Corporation", the "Company", "Sparta Group", "Sparta Capital", "SAY.V" or "Sparta") is launching an Autonomous Medicine Project, bringing together several of the Company's technology partners to potentially transform healthcare delivery in situations where access to medical assistance is limited or slow, including remote areas like Canada's northern Territories.
When complete, the project is expected to offer healthcare professionals a medical decision support software that is Health Canada/FDA approved as a medical device and is capable of autonomously diagnosing illness and prescribing treatment. The project is initiated through Sparta's newly formed division, Sparta Health Corp.
"This final product is meant to support doctors, nurses, or other healthcare professionals, as they work to serve patients effectively and efficiently. With our system, we expect that more people will not only receive quicker access to the medical help they need, the information provided will be based on the world's most current medical evidence," said John O'Bireck, President and CTO of Sparta.
Sparta's Autonomous Medicine System ("AMS", or "Doc-in-a-Box") originated in a 2013 Canadian Space Agency ("CSA") concept study, specifically a manned exploration to Mars. A video demonstrates future possibilities of such a system, but the study confirmed its feasibility. Two of the authors of the study are now valued members of Sparta's Technical Advisory Board ("TAB") and continue to work on developing various key components of the system. Sparta's newly formed Sparta Health Corporation is working to carry the transformative technology over the finish line.
Lesen Sie auch
During a medical incident Doc-in-a-Box™ can be used by a trained medical observer, such as an EMT, nurse, or physician. Essentially, the medical professional is guided in the collection of symptoms thus allowing the technology to establish a diagnosis and subsequent treatment because it has relied on the most up-to-date evidence-based medicine. Analogous to the recently popularized ChatGPT® platform, Doc-in-a-Box™ applies a similar form of Natural Language Processing ("NLP"). In this case, to medical guidelines and clinical research to maintain a current knowledge base.